Figure 2.
Elevated platelet count depending on the treatment duration in patients with: (a) platelet count within normal ranges prior to sirolimus treatment, (b) thrombocytosis prior to sirolimus treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.